Literature DB >> 31342447

Neuroemergencies in South America: How to Fill in the Gaps?

Gisele Sampaio Silva1, Nelson J Maldonado2, Jorge H Mejia-Mantilla3, Santiago Ortega-Gutierrez4, Jan Claassen5, Panayiotis Varelas6, Jose I Suarez7.   

Abstract

South America is a subcontinent with 393 million inhabitants with widely distinct countries and diverse ethnicities, cultures, political and societal organizations. The epidemiological transition that accompanied the technological and demographic evolution is happening in South America and leading to a rise in the incidence of neurodegenerative and cardiovascular diseases that now coexist with the still high burden of infectious diseases. South America is also quite heterogeneous regarding the existence of systems of care for the various neurological emergencies, with some countries having well-organized systems for some diseases, while others have no plan of action for the care of patients with acute neurological symptoms. In this article, we discuss the existing systems of care in different countries of South America for the treatment of neurological emergencies, mainly stroke, status epilepticus, and traumatic brain injury. We also will address existing gaps between the current systems and recommendations from the literature to improve the management of such emergencies, as well as strategies on how to solve these disparities.

Entities:  

Keywords:  Critical care; Health policy; Neurocritical care; Neurological emergency; Outcome; South America

Mesh:

Year:  2019        PMID: 31342447     DOI: 10.1007/s12028-019-00775-8

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  73 in total

1.  The impending global epidemic of cardiovascular diseases.

Authors:  S Ounpuu; S Anand; S Yusuf
Journal:  Eur Heart J       Date:  2000-06       Impact factor: 29.983

2.  [Epidemiological transition in Latin America: a comparison of four countries].

Authors:  C Albala; F Vio; M Yáñez
Journal:  Rev Med Chil       Date:  1997-06       Impact factor: 0.553

3.  Prevalence of stroke at high altitude (3380 m) in Cuzco, a town of Peru. A population-based study.

Authors:  A S Jaillard; M Hommel; P Mazetti
Journal:  Stroke       Date:  1995-04       Impact factor: 7.914

4.  Incidence, 30-day case-fatality rate, and prognosis of stroke in Iquique, Chile: a 2-year community-based prospective study (PISCIS project).

Authors:  Pablo M Lavados; Claudio Sacks; Liliana Prina; Arturo Escobar; Claudia Tossi; Fernando Araya; Walter Feuerhake; Marcelo Galvez; Rodrigo Salinas; Gonzalo Alvarez
Journal:  Lancet       Date:  2005 Jun 25-Jul 1       Impact factor: 79.321

Review 5.  Stroke in Latin America: Burden of Disease and Opportunities for Prevention.

Authors:  Álvaro Avezum; Francisco F Costa-Filho; Alexandre Pieri; Sheila O Martins; José A Marin-Neto
Journal:  Glob Heart       Date:  2015-02-07

6.  Tobacco use and the cardiovascular disease epidemic in developing countries: global crises and opportunity in the making.

Authors:  Samira Asma; George A Mensah; Charles W Warren; Rosemarie Henson
Journal:  Ethn Dis       Date:  2003       Impact factor: 1.847

7.  Stroke incidence, prognosis, 30-day, and 1-year case fatality rates in Matão, Brazil: a population-based prospective study.

Authors:  Cesar Minelli; Lee Fu Fen; Denise P Camara Minelli
Journal:  Stroke       Date:  2007-10-04       Impact factor: 7.914

Review 8.  Stroke epidemiology, prevention, and management strategies at a regional level: Latin America and the Caribbean.

Authors:  Pablo M Lavados; Anselm J M Hennis; Jefferson G Fernandes; Marco T Medina; Branca Legetic; Arnold Hoppe; Claudio Sacks; Liliana Jadue; Rodrigo Salinas
Journal:  Lancet Neurol       Date:  2007-04       Impact factor: 44.182

9.  National research for health systems in Latin America and the Caribbean: moving towards the right direction?

Authors:  Francisco Becerra-Posada; Miryam Minayo; Cristiane Quental; Sylvia de Haan
Journal:  Health Res Policy Syst       Date:  2014-03-06

10.  Diverse Empirical Evidence on Epidemiological Transition in Low- and Middle-Income Countries: Population-Based Findings from INDEPTH Network Data.

Authors:  Ailiana Santosa; Peter Byass
Journal:  PLoS One       Date:  2016-05-17       Impact factor: 3.240

View more
  4 in total

1.  Management of Refractory Status Epilepticus: An International Cohort Study (MORSE CODe) Analysis of Patients Managed in the ICU.

Authors:  Wei-Ting Chiu; Vanessa Campozano; Alois Schiefecker; Dannys Rivero Rodriguez; Daniel Ferreira; Amy Headlee; Sinead Zeidan; Alexandra Grinea; Yao-Hsien Huang; Kevin Doyle; Qi Shen; Diana Gómez; Sara E Hocker; Benjamin Rohaut; Romain Sonneville; Chien-Tai Hong; Sophie Demeret; Pedro Kurtz; Nelson Maldonado; Raimund Helbok; Telmo Fernandez; Jan Claassen
Journal:  Neurology       Date:  2022-08-02       Impact factor: 11.800

2.  Common Data Elements for Unruptured Intracranial Aneurysms and Subarachnoid Hemorrhage Clinical Research: A National Institute for Neurological Disorders and Stroke and National Library of Medicine Project.

Authors:  Jose I Suarez; Muniza K Sheikh; R Loch Macdonald; Sepideh Amin-Hanjani; Robert D Brown; Airton Leonardo de Oliveira Manoel; Colin P Derdeyn; Nima Etminan; Emanuela Keller; Peter D Leroux; Stephan A Mayer; Akio Morita; Gabriel Rinkel; Daniel Rufennacht; Martin N Stienen; James Torner; Mervyn D I Vergouwen; George K C Wong
Journal:  Neurocrit Care       Date:  2019-06       Impact factor: 3.210

3.  Predictors of high functional disability and mortality at 3 months in patients with status epilepticus.

Authors:  Dannys Rivero Rodríguez; Graham Pluck
Journal:  eNeurologicalSci       Date:  2021-12-24

4.  A Perspective from the Neurocritical Care Society and the Society of Critical Care Medicine: Team-Based Care for Neurological Critical Illness.

Authors:  Lewis Kaplan; Asma M Moheet; Sarah L Livesay; J Javier Provencio; Jose I Suarez; Mary Kay Bader; Heatherlee Bailey; Cherylee W J Chang
Journal:  Neurocrit Care       Date:  2020-04       Impact factor: 3.210

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.